Williams RT - Search Results

1

The ARF tumor suppressor in acute leukemias: insights from mouse models of Bcr-Abl-induced acute lymphoblastic leukemia.

Williams RT, Sherr CJ. Williams RT, et al. Adv Exp Med Biol. 2007;604:107-14. doi: 10.1007/978-0-387-69116-9_9. Adv Exp Med Biol. 2007. PMID: 17695724 Review.

2

p53-Dependent and -independent functions of the Arf tumor suppressor.

Sherr CJ, Bertwistle D, DEN Besten W, Kuo ML, Sugimoto M, Tago K, Williams RT, Zindy F, Roussel MF. Sherr CJ, et al. Among authors: williams rt. Cold Spring Harb Symp Quant Biol. 2005;70:129-37. doi: 10.1101/sqb.2005.70.004. Cold Spring Harb Symp Quant Biol. 2005. PMID: 16869746 Review.

3

The INK4-ARF (CDKN2A/B) locus in hematopoiesis and BCR-ABL-induced leukemias.

Williams RT, Sherr CJ. Williams RT, et al. Cold Spring Harb Symp Quant Biol. 2008;73:461-7. doi: 10.1101/sqb.2008.73.039. Epub 2008 Nov 21. Cold Spring Harb Symp Quant Biol. 2008. PMID: 19028987 Review.

4

Arf tumor suppressor promoter monitors latent oncogenic signals in vivo.

Zindy F, Williams RT, Baudino TA, Rehg JE, Skapek SX, Cleveland JL, Roussel MF, Sherr CJ. Zindy F, et al. Among authors: williams rt. Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15930-5. doi: 10.1073/pnas.2536808100. Epub 2003 Dec 9. Proc Natl Acad Sci U S A. 2003. PMID: 14665695 Free PMC article.

5

Myeloid leukemia-associated nucleophosmin mutants perturb p53-dependent and independent activities of the Arf tumor suppressor protein.

den Besten W, Kuo ML, Williams RT, Sherr CJ. den Besten W, et al. Among authors: williams rt. Cell Cycle. 2005 Nov;4(11):1593-8. doi: 10.4161/cc.4.11.2174. Epub 2005 Nov 14. Cell Cycle. 2005. PMID: 16205118

6

Arf gene loss enhances oncogenicity and limits imatinib response in mouse models of Bcr-Abl-induced acute lymphoblastic leukemia.

Williams RT, Roussel MF, Sherr CJ. Williams RT, et al. Proc Natl Acad Sci U S A. 2006 Apr 25;103(17):6688-93. doi: 10.1073/pnas.0602030103. Epub 2006 Apr 17. Proc Natl Acad Sci U S A. 2006. PMID: 16618932 Free PMC article.

7

Ubiquitination of, and sumoylation by, the Arf tumor suppressor.

den Besten W, Kuo ML, Tago K, Williams RT, Sherr CJ. den Besten W, et al. Among authors: williams rt. Isr Med Assoc J. 2006 Apr;8(4):249-51. Isr Med Assoc J. 2006. PMID: 16671360 Free article.

8

Cytokine-dependent imatinib resistance in mouse BCR-ABL+, Arf-null lymphoblastic leukemia.

Williams RT, den Besten W, Sherr CJ. Williams RT, et al. Genes Dev. 2007 Sep 15;21(18):2283-7. doi: 10.1101/gad.1588607. Epub 2007 Aug 30. Genes Dev. 2007. PMID: 17761812 Free PMC article.

9

Failure of CDKN2A/B (INK4A/B-ARF)-mediated tumor suppression and resistance to targeted therapy in acute lymphoblastic leukemia induced by BCR-ABL.

Mullighan CG, Williams RT, Downing JR, Sherr CJ. Mullighan CG, et al. Among authors: williams rt. Genes Dev. 2008 Jun 1;22(11):1411-5. doi: 10.1101/gad.1673908. Genes Dev. 2008. PMID: 18519632 Free PMC article.

10

Stage-specific Arf tumor suppression in Notch1-induced T-cell acute lymphoblastic leukemia.

Volanakis EJ, Williams RT, Sherr CJ. Volanakis EJ, et al. Among authors: williams rt. Blood. 2009 Nov 12;114(20):4451-9. doi: 10.1182/blood-2009-07-233346. Epub 2009 Sep 16. Blood. 2009. PMID: 19759355 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

469 results

Search Page